• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I FREE T4 REAGENT KIT; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I FREE T4 REAGENT KIT; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Catalog Number 07P70-20
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/05/2024
Event Type  malfunction  
Manufacturer Narrative
Section a1 - patient identifier: complete sid is (b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed falsely elevated alinity i free t4 result generated on the alinity i processing module for one patient.The customer repeated the sample on the roche platform and on the alinity i processing module and the results were in the normal range.The following data was provided: customer¿s normal range: 9.01 to 19.05 pmol/l sid (b)(6) initial result = >64.35 pmol/l; repeat result = 12.15 pmol/l roche result = 15.1 pmol/l there was no impact to patient management reported.
 
Event Description
The customer observed falsely elevated alinity i free t4 result generated on the alinity i processing module for one patient.The customer repeated the sample on the roche platform and on the alinity i processing module and the results were in the normal range.The following data was provided: customer¿s normal range: 9.01 to 19.05 pmol/l sid (b)(6)initial result = >64.35 pmol/l; repeat result = 12.15 pmol/l roche result = 15.1 pmol/l there was no impact to patient management reported.
 
Manufacturer Narrative
The complaint investigation for falsely elevated alinity i free t4 result included a review of data and information provided by the customer, ticket trending review, device history record review, and labeling review.Return testing was not completed as returns were not available.The data and information provided by the customer were reviewed and support the complaint issue.A review of the complaint trending report did not identify any trends for the issue for the product.A review of the device history record did not identify any non-conformances or deviations with lot number 53312ud00 and the complaint issue.A review of labeling was performed and found to sufficiently address the customer's issue.Per product labeling, to ensure consistency in results, recentrifuge specimens prior to testing if they contain fibrin, red blood cells, or other particulate matter.Reagent handling and storage instructions are provided in the package insert, including precautions to minimize the risk of contamination and the potential to compromise reagent performance.Additionally, results should be used in conjunction with other data, e.G., symptoms, results of other thyroid tests, clinical impressions, etc.If the free t4 results are inconsistent with clinical evidence, additional testing is suggested to confirm the result.Based on this investigation, no systemic issue or deficiency was identified with the alinity i free t4 reagent, lot number 53312ud00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I FREE T4 REAGENT KIT
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18767635
MDR Text Key336113736
Report Number3005094123-2024-00072
Device Sequence Number1
Product Code CEC
UDI-Device Identifier00380740121815
UDI-Public(01)00380740121815(17)240524(10)53312UD00
Combination Product (y/n)N
Reporter Country CodeVM
PMA/PMN Number
K173122
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/24/2024
Device Catalogue Number07P70-20
Device Lot Number53312UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/05/2024
Initial Date FDA Received02/23/2024
Supplement Dates Manufacturer Received03/22/2024
Supplement Dates FDA Received03/29/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/03/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, (B)(6); ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
-
-